NIOX Group PLC (NIOX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, NIOX Group PLC (NIOX) has a cash flow conversion efficiency ratio of 0.130x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX8.80 Million ≈ $1.07K USD) by net assets (GBX67.60 Million ≈ $8.22K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NIOX Group PLC defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
NIOX Group PLC - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how NIOX Group PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
NIOX Group PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NIOX Group PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Timah Resources Ltd
AU:TML
|
0.007x |
|
Arkadia Digital Media Tbk PT
JK:DIGI
|
0.084x |
|
Colabor Group Inc.
TO:GCL
|
0.101x |
|
Universal Biosensors Inc
AU:UBI
|
-0.301x |
|
Cullen Resources Ltd
AU:CUL
|
0.183x |
|
Eguana Technologies Inc
V:EGT
|
0.006x |
|
Railway Metrics & Dynamics Sweden AB
ST:RMDX
|
0.026x |
|
Damon Inc. Common Stock
NASDAQ:DMN
|
0.392x |
Annual Cash Flow Conversion Efficiency for NIOX Group PLC (2013–2025)
The table below shows the annual cash flow conversion efficiency of NIOX Group PLC from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see NIOX Group PLC market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | GBX67.60 Million ≈ $8.22K |
GBX15.80 Million ≈ $1.92K |
0.234x | -19.15% |
| 2024-12-31 | GBX59.50 Million ≈ $7.24K |
GBX17.20 Million ≈ $2.09K |
0.289x | +108.83% |
| 2023-12-31 | GBX83.80 Million ≈ $10.20K |
GBX11.60 Million ≈ $1.41K |
0.138x | 0.00% |
| 2023-12-30 | GBX83.80 Million ≈ $10.20K |
GBX11.60 Million ≈ $1.41K |
0.138x | +69.21% |
| 2022-12-31 | GBX81.90 Million ≈ $9.96K |
GBX6.70 Million ≈ $815.20 |
0.082x | 0.00% |
| 2022-12-30 | GBX81.90 Million ≈ $9.96K |
GBX6.70 Million ≈ $815.20 |
0.082x | +290.34% |
| 2021-12-31 | GBX66.80 Million ≈ $8.13K |
GBX1.40 Million ≈ $170.34 |
0.021x | 0.00% |
| 2021-12-30 | GBX66.80 Million ≈ $8.13K |
GBX1.40 Million ≈ $170.34 |
0.021x | +105.80% |
| 2020-12-31 | GBX66.10 Million ≈ $8.04K |
GBX-23.90 Million ≈ $-2.91K |
-0.362x | 0.00% |
| 2020-12-30 | GBX66.10 Million ≈ $8.04K |
GBX-23.90 Million ≈ $-2.91K |
-0.362x | -22.16% |
| 2019-12-31 | GBX84.80 Million ≈ $10.32K |
GBX-25.10 Million ≈ $-3.05K |
-0.296x | 0.00% |
| 2019-12-30 | GBX84.80 Million ≈ $10.32K |
GBX-25.10 Million ≈ $-3.05K |
-0.296x | -33.41% |
| 2018-12-31 | GBX183.00 Million ≈ $22.27K |
GBX-40.60 Million ≈ $-4.94K |
-0.222x | 0.00% |
| 2018-12-30 | GBX183.00 Million ≈ $22.27K |
GBX-40.60 Million ≈ $-4.94K |
-0.222x | -43.13% |
| 2017-12-31 | GBX371.60 Million ≈ $45.21K |
GBX-57.60 Million ≈ $-7.01K |
-0.155x | 0.00% |
| 2017-12-30 | GBX371.60 Million ≈ $45.21K |
GBX-57.60 Million ≈ $-7.01K |
-0.155x | +14.54% |
| 2016-12-31 | GBX312.60 Million ≈ $38.03K |
GBX-56.70 Million ≈ $-6.90K |
-0.181x | 0.00% |
| 2016-12-30 | GBX312.60 Million ≈ $38.03K |
GBX-56.70 Million ≈ $-6.90K |
-0.181x | -43.32% |
| 2015-12-31 | GBX440.90 Million ≈ $53.64K |
GBX-55.80 Million ≈ $-6.79K |
-0.127x | 0.00% |
| 2015-12-30 | GBX440.90 Million ≈ $53.64K |
GBX-55.80 Million ≈ $-6.79K |
-0.127x | +34.56% |
| 2014-12-31 | GBX190.80 Million ≈ $23.21K |
GBX-36.90 Million ≈ $-4.49K |
-0.193x | 0.00% |
| 2014-12-30 | GBX190.80 Million ≈ $23.21K |
GBX-36.90 Million ≈ $-4.49K |
-0.193x | +67.50% |
| 2013-12-31 | GBX30.05 Million ≈ $3.66K |
GBX-17.88 Million ≈ $-2.18K |
-0.595x | 0.00% |
| 2013-12-30 | GBX30.05 Million ≈ $3.66K |
GBX-17.88 Million ≈ $-2.18K |
-0.595x | -- |
About NIOX Group PLC
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide … Read more